 | • レポートコード：MRC2-11QY10546 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は破傷風トキソイドワクチンのグローバル市場について調査・分析したレポートです。種類別（一価破傷風トキソイド（TT）、ジフテリア、破傷風、百日咳（DTaP）、ジフテリア・破傷風（DT））市場規模、用途別（病院・診療所、政府機関、研究、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別破傷風トキソイドワクチンの競争状況、市場シェア ・世界の破傷風トキソイドワクチン市場：種類別市場規模 2015年-2020年（一価破傷風トキソイド（TT）、ジフテリア、破傷風、百日咳（DTaP）、ジフテリア・破傷風（DT）） ・世界の破傷風トキソイドワクチン市場：種類別市場規模予測 2021年-2026年（一価破傷風トキソイド（TT）、ジフテリア、破傷風、百日咳（DTaP）、ジフテリア・破傷風（DT）） ・世界の破傷風トキソイドワクチン市場：用途別市場規模 2015年-2020年（病院・診療所、政府機関、研究、その他） ・世界の破傷風トキソイドワクチン市場：用途別市場規模予測 2021年-2026年（病院・診療所、政府機関、研究、その他） ・北米の破傷風トキソイドワクチン市場分析：米国、カナダ ・ヨーロッパの破傷風トキソイドワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの破傷風トキソイドワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の破傷風トキソイドワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの破傷風トキソイドワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Merck、Pfizer、Sanofi Pasteur、AstraZeneca、Bharat Biotech、Shenzhen Kangtai Biological Products、Bausch Health、Emergent Biosolutions、Astellas Pharma、Panacea Biotec ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms.
US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare.
Market Analysis and Insights: Global Tetanus Toxoid Vaccine Market
The global Tetanus Toxoid Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tetanus Toxoid Vaccine Scope and Market Size
Tetanus Toxoid Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tetanus Toxoid Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Tetanus Toxoid Vaccine market is segmented into
Monovalent Tetanus Toxoid (TT)
Diphtheria
Tetanus
Pertussis (DTaP)
Diphtheria and Tetanus (DT)
Segment by Application, the Tetanus Toxoid Vaccine market is segmented into
Hospitals And Clinics
Government Organizations
Research
Others
Regional and Country-level Analysis
The Tetanus Toxoid Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tetanus Toxoid Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tetanus Toxoid Vaccine Market Share Analysis
Tetanus Toxoid Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tetanus Toxoid Vaccine business, the date to enter into the Tetanus Toxoid Vaccine market, Tetanus Toxoid Vaccine product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Shenzhen Kangtai Biological Products
Bausch Health
Emergent Biosolutions
Astellas Pharma
Panacea Biotec
1 Study Coverage
1.1 Tetanus Toxoid Vaccine Product Introduction
1.2 Market Segments
1.3 Key Tetanus Toxoid Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tetanus Toxoid Vaccine Market Size Growth Rate by Type
1.4.2 Monovalent Tetanus Toxoid (TT)
1.4.3 Diphtheria
1.4.4 Tetanus
1.4.5 Pertussis (DTaP)
1.4.6 Diphtheria and Tetanus (DT)
1.5 Market by Application
1.5.1 Global Tetanus Toxoid Vaccine Market Size Growth Rate by Application
1.5.2 Hospitals And Clinics
1.5.3 Government Organizations
1.5.4 Research
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tetanus Toxoid Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Tetanus Toxoid Vaccine Revenue 2015-2026
2.1.2 Global Tetanus Toxoid Vaccine Sales 2015-2026
2.2 Global Tetanus Toxoid Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tetanus Toxoid Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tetanus Toxoid Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tetanus Toxoid Vaccine Competitor Landscape by Players
3.1 Tetanus Toxoid Vaccine Sales by Manufacturers
3.1.1 Tetanus Toxoid Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Tetanus Toxoid Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Tetanus Toxoid Vaccine Revenue by Manufacturers
3.2.1 Tetanus Toxoid Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Tetanus Toxoid Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tetanus Toxoid Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tetanus Toxoid Vaccine Revenue in 2019
3.2.5 Global Tetanus Toxoid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tetanus Toxoid Vaccine Price by Manufacturers
3.4 Tetanus Toxoid Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Tetanus Toxoid Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tetanus Toxoid Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Tetanus Toxoid Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tetanus Toxoid Vaccine Market Size by Type (2015-2020)
4.1.1 Global Tetanus Toxoid Vaccine Sales by Type (2015-2020)
4.1.2 Global Tetanus Toxoid Vaccine Revenue by Type (2015-2020)
4.1.3 Tetanus Toxoid Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tetanus Toxoid Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Tetanus Toxoid Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Tetanus Toxoid Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Tetanus Toxoid Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tetanus Toxoid Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tetanus Toxoid Vaccine Market Size by Application (2015-2020)
5.1.1 Global Tetanus Toxoid Vaccine Sales by Application (2015-2020)
5.1.2 Global Tetanus Toxoid Vaccine Revenue by Application (2015-2020)
5.1.3 Tetanus Toxoid Vaccine Price by Application (2015-2020)
5.2 Tetanus Toxoid Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Tetanus Toxoid Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Tetanus Toxoid Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Tetanus Toxoid Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tetanus Toxoid Vaccine by Country
6.1.1 North America Tetanus Toxoid Vaccine Sales by Country
6.1.2 North America Tetanus Toxoid Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tetanus Toxoid Vaccine Market Facts & Figures by Type
6.3 North America Tetanus Toxoid Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Tetanus Toxoid Vaccine by Country
7.1.1 Europe Tetanus Toxoid Vaccine Sales by Country
7.1.2 Europe Tetanus Toxoid Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tetanus Toxoid Vaccine Market Facts & Figures by Type
7.3 Europe Tetanus Toxoid Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tetanus Toxoid Vaccine by Region
8.1.1 Asia Pacific Tetanus Toxoid Vaccine Sales by Region
8.1.2 Asia Pacific Tetanus Toxoid Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tetanus Toxoid Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Tetanus Toxoid Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tetanus Toxoid Vaccine by Country
9.1.1 Latin America Tetanus Toxoid Vaccine Sales by Country
9.1.2 Latin America Tetanus Toxoid Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tetanus Toxoid Vaccine Market Facts & Figures by Type
9.3 Central & South America Tetanus Toxoid Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tetanus Toxoid Vaccine by Country
10.1.1 Middle East and Africa Tetanus Toxoid Vaccine Sales by Country
10.1.2 Middle East and Africa Tetanus Toxoid Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tetanus Toxoid Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Tetanus Toxoid Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Tetanus Toxoid Vaccine Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Tetanus Toxoid Vaccine Products Offered
11.2.5 Merck Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Tetanus Toxoid Vaccine Products Offered
11.3.5 Pfizer Related Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Description and Business Overview
11.4.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Pasteur Tetanus Toxoid Vaccine Products Offered
11.4.5 Sanofi Pasteur Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Tetanus Toxoid Vaccine Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Bharat Biotech
11.6.1 Bharat Biotech Corporation Information
11.6.2 Bharat Biotech Description and Business Overview
11.6.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bharat Biotech Tetanus Toxoid Vaccine Products Offered
11.6.5 Bharat Biotech Related Developments
11.7 Shenzhen Kangtai Biological Products
11.7.1 Shenzhen Kangtai Biological Products Corporation Information
11.7.2 Shenzhen Kangtai Biological Products Description and Business Overview
11.7.3 Shenzhen Kangtai Biological Products Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Shenzhen Kangtai Biological Products Tetanus Toxoid Vaccine Products Offered
11.7.5 Shenzhen Kangtai Biological Products Related Developments
11.8 Bausch Health
11.8.1 Bausch Health Corporation Information
11.8.2 Bausch Health Description and Business Overview
11.8.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bausch Health Tetanus Toxoid Vaccine Products Offered
11.8.5 Bausch Health Related Developments
11.9 Emergent Biosolutions
11.9.1 Emergent Biosolutions Corporation Information
11.9.2 Emergent Biosolutions Description and Business Overview
11.9.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Emergent Biosolutions Tetanus Toxoid Vaccine Products Offered
11.9.5 Emergent Biosolutions Related Developments
11.10 Astellas Pharma
11.10.1 Astellas Pharma Corporation Information
11.10.2 Astellas Pharma Description and Business Overview
11.10.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Astellas Pharma Tetanus Toxoid Vaccine Products Offered
11.10.5 Astellas Pharma Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Tetanus Toxoid Vaccine Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tetanus Toxoid Vaccine Market Estimates and Projections by Region
12.1.1 Global Tetanus Toxoid Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Tetanus Toxoid Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Tetanus Toxoid Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Tetanus Toxoid Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Tetanus Toxoid Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Tetanus Toxoid Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Tetanus Toxoid Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Tetanus Toxoid Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Tetanus Toxoid Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Tetanus Toxoid Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tetanus Toxoid Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tetanus Toxoid Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tetanus Toxoid Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tetanus Toxoid Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Tetanus Toxoid Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Tetanus Toxoid Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Tetanus Toxoid Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Tetanus Toxoid Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tetanus Toxoid Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tetanus Toxoid Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tetanus Toxoid Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tetanus Toxoid Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tetanus Toxoid Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tetanus Toxoid Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Tetanus Toxoid Vaccine Market Segments
Table 2. Ranking of Global Top Tetanus Toxoid Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tetanus Toxoid Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Monovalent Tetanus Toxoid (TT)
Table 5. Major Manufacturers of Diphtheria
Table 6. Major Manufacturers of Tetanus
Table 7. Major Manufacturers of Pertussis (DTaP)
Table 8. Major Manufacturers of Diphtheria and Tetanus (DT)
Table 9. Global Tetanus Toxoid Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Tetanus Toxoid Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Tetanus Toxoid Vaccine Sales by Regions 2015-2020 (K Units)
Table 12. Global Tetanus Toxoid Vaccine Sales Market Share by Regions (2015-2020)
Table 13. Global Tetanus Toxoid Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Tetanus Toxoid Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Tetanus Toxoid Vaccine Sales Share by Manufacturers (2015-2020)
Table 16. Global Tetanus Toxoid Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Tetanus Toxoid Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tetanus Toxoid Vaccine as of 2019)
Table 18. Tetanus Toxoid Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Tetanus Toxoid Vaccine Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Tetanus Toxoid Vaccine Price (2015-2020) (USD/Unit)
Table 21. Tetanus Toxoid Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Tetanus Toxoid Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Tetanus Toxoid Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Tetanus Toxoid Vaccine Sales by Type (2015-2020) (K Units)
Table 26. Global Tetanus Toxoid Vaccine Sales Share by Type (2015-2020)
Table 27. Global Tetanus Toxoid Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Tetanus Toxoid Vaccine Revenue Share by Type (2015-2020)
Table 29. Tetanus Toxoid Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Tetanus Toxoid Vaccine Sales by Application (2015-2020) (K Units)
Table 31. Global Tetanus Toxoid Vaccine Sales Share by Application (2015-2020)
Table 32. North America Tetanus Toxoid Vaccine Sales by Country (2015-2020) (K Units)
Table 33. North America Tetanus Toxoid Vaccine Sales Market Share by Country (2015-2020)
Table 34. North America Tetanus Toxoid Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Tetanus Toxoid Vaccine Revenue Market Share by Country (2015-2020)
Table 36. North America Tetanus Toxoid Vaccine Sales by Type (2015-2020) (K Units)
Table 37. North America Tetanus Toxoid Vaccine Sales Market Share by Type (2015-2020)
Table 38. North America Tetanus Toxoid Vaccine Sales by Application (2015-2020) (K Units)
Table 39. North America Tetanus Toxoid Vaccine Sales Market Share by Application (2015-2020)
Table 40. Europe Tetanus Toxoid Vaccine Sales by Country (2015-2020) (K Units)
Table 41. Europe Tetanus Toxoid Vaccine Sales Market Share by Country (2015-2020)
Table 42. Europe Tetanus Toxoid Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Tetanus Toxoid Vaccine Revenue Market Share by Country (2015-2020)
Table 44. Europe Tetanus Toxoid Vaccine Sales by Type (2015-2020) (K Units)
Table 45. Europe Tetanus Toxoid Vaccine Sales Market Share by Type (2015-2020)
Table 46. Europe Tetanus Toxoid Vaccine Sales by Application (2015-2020) (K Units)
Table 47. Europe Tetanus Toxoid Vaccine Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Tetanus Toxoid Vaccine Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Tetanus Toxoid Vaccine Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Tetanus Toxoid Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Tetanus Toxoid Vaccine Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Tetanus Toxoid Vaccine Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Tetanus Toxoid Vaccine Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Tetanus Toxoid Vaccine Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Tetanus Toxoid Vaccine Sales Market Share by Application (2015-2020)
Table 56. Latin America Tetanus Toxoid Vaccine Sales by Country (2015-2020) (K Units)
Table 57. Latin America Tetanus Toxoid Vaccine Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Tetanus Toxoid Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Tetanus Toxoid Vaccine Revenue Market Share by Country (2015-2020)
Table 60. Latin America Tetanus Toxoid Vaccine Sales by Type (2015-2020) (K Units)
Table 61. Latin America Tetanus Toxoid Vaccine Sales Market Share by Type (2015-2020)
Table 62. Latin America Tetanus Toxoid Vaccine Sales by Application (2015-2020) (K Units)
Table 63. Latin America Tetanus Toxoid Vaccine Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Tetanus Toxoid Vaccine Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Tetanus Toxoid Vaccine Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Tetanus Toxoid Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Tetanus Toxoid Vaccine Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Tetanus Toxoid Vaccine Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Tetanus Toxoid Vaccine Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Tetanus Toxoid Vaccine Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Tetanus Toxoid Vaccine Sales Market Share by Application (2015-2020)
Table 72. GlaxoSmithKline Corporation Information
Table 73. GlaxoSmithKline Description and Major Businesses
Table 74. GlaxoSmithKline Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. GlaxoSmithKline Product
Table 76. GlaxoSmithKline Recent Development
Table 77. Merck Corporation Information
Table 78. Merck Description and Major Businesses
Table 79. Merck Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Merck Product
Table 81. Merck Recent Development
Table 82. Pfizer Corporation Information
Table 83. Pfizer Description and Major Businesses
Table 84. Pfizer Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Pfizer Product
Table 86. Pfizer Recent Development
Table 87. Sanofi Pasteur Corporation Information
Table 88. Sanofi Pasteur Description and Major Businesses
Table 89. Sanofi Pasteur Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Sanofi Pasteur Product
Table 91. Sanofi Pasteur Recent Development
Table 92. AstraZeneca Corporation Information
Table 93. AstraZeneca Description and Major Businesses
Table 94. AstraZeneca Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. AstraZeneca Product
Table 96. AstraZeneca Recent Development
Table 97. Bharat Biotech Corporation Information
Table 98. Bharat Biotech Description and Major Businesses
Table 99. Bharat Biotech Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Bharat Biotech Product
Table 101. Bharat Biotech Recent Development
Table 102. Shenzhen Kangtai Biological Products Corporation Information
Table 103. Shenzhen Kangtai Biological Products Description and Major Businesses
Table 104. Shenzhen Kangtai Biological Products Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Shenzhen Kangtai Biological Products Product
Table 106. Shenzhen Kangtai Biological Products Recent Development
Table 107. Bausch Health Corporation Information
Table 108. Bausch Health Description and Major Businesses
Table 109. Bausch Health Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Bausch Health Product
Table 111. Bausch Health Recent Development
Table 112. Emergent Biosolutions Corporation Information
Table 113. Emergent Biosolutions Description and Major Businesses
Table 114. Emergent Biosolutions Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Emergent Biosolutions Product
Table 116. Emergent Biosolutions Recent Development
Table 117. Astellas Pharma Corporation Information
Table 118. Astellas Pharma Description and Major Businesses
Table 119. Astellas Pharma Tetanus Toxoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Astellas Pharma Product
Table 121. Astellas Pharma Recent Development
Table 122. Panacea Biotec Corporation Information
Table 123. Panacea Biotec Description and Major Businesses
Table 124. Panacea Biotec Tetanus Toxoid Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Panacea Biotec Product
Table 126. Panacea Biotec Recent Development
Table 127. Global Tetanus Toxoid Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 128. Global Tetanus Toxoid Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Tetanus Toxoid Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Tetanus Toxoid Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Tetanus Toxoid Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 132. North America: Tetanus Toxoid Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Tetanus Toxoid Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 134. Europe: Tetanus Toxoid Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Tetanus Toxoid Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 136. Asia Pacific: Tetanus Toxoid Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Tetanus Toxoid Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 138. Latin America: Tetanus Toxoid Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Tetanus Toxoid Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 140. Middle East and Africa: Tetanus Toxoid Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Tetanus Toxoid Vaccine Players
Table 145. Tetanus Toxoid Vaccine Customers List
Table 146. Tetanus Toxoid Vaccine Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Tetanus Toxoid Vaccine Product Picture
Figure 2. Global Tetanus Toxoid Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Monovalent Tetanus Toxoid (TT) Product Picture
Figure 4. Diphtheria Product Picture
Figure 5. Tetanus Product Picture
Figure 6. Pertussis (DTaP) Product Picture
Figure 7. Diphtheria and Tetanus (DT) Product Picture
Figure 8. Global Tetanus Toxoid Vaccine Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals And Clinics
Figure 10. Government Organizations
Figure 11. Research
Figure 12. Others
Figure 13. Tetanus Toxoid Vaccine Report Years Considered
Figure 14. Global Tetanus Toxoid Vaccine Market Size 2015-2026 (US$ Million)
Figure 15. Global Tetanus Toxoid Vaccine Sales 2015-2026 (K Units)
Figure 16. Global Tetanus Toxoid Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Tetanus Toxoid Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Tetanus Toxoid Vaccine Sales Market Share by Region in 2019
Figure 19. Global Tetanus Toxoid Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Tetanus Toxoid Vaccine Revenue Market Share by Region in 2019
Figure 21. Global Tetanus Toxoid Vaccine Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Tetanus Toxoid Vaccine Revenue in 2019
Figure 23. Tetanus Toxoid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Tetanus Toxoid Vaccine Sales Market Share by Type (2015-2020)
Figure 25. Global Tetanus Toxoid Vaccine Sales Market Share by Type in 2019
Figure 26. Global Tetanus Toxoid Vaccine Revenue Market Share by Type (2015-2020)
Figure 27. Global Tetanus Toxoid Vaccine Revenue Market Share by Type in 2019
Figure 28. Global Tetanus Toxoid Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global Tetanus Toxoid Vaccine Sales Market Share by Application (2015-2020)
Figure 30. Global Tetanus Toxoid Vaccine Sales Market Share by Application in 2019
Figure 31. Global Tetanus Toxoid Vaccine Revenue Market Share by Application (2015-2020)
Figure 32. Global Tetanus Toxoid Vaccine Revenue Market Share by Application in 2019
Figure 33. North America Tetanus Toxoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Tetanus Toxoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Tetanus Toxoid Vaccine Sales Market Share by Country in 2019
Figure 36. North America Tetanus Toxoid Vaccine Revenue Market Share by Country in 2019
Figure 37. U.S. Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Tetanus Toxoid Vaccine Market Share by Type in 2019
Figure 42. North America Tetanus Toxoid Vaccine Market Share by Application in 2019
Figure 43. Europe Tetanus Toxoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Tetanus Toxoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Tetanus Toxoid Vaccine Sales Market Share by Country in 2019
Figure 46. Europe Tetanus Toxoid Vaccine Revenue Market Share by Country in 2019
Figure 47. Germany Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Tetanus Toxoid Vaccine Market Share by Type in 2019
Figure 58. Europe Tetanus Toxoid Vaccine Market Share by Application in 2019
Figure 59. Asia Pacific Tetanus Toxoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Tetanus Toxoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Tetanus Toxoid Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Tetanus Toxoid Vaccine Revenue Market Share by Region in 2019
Figure 63. China Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Tetanus Toxoid Vaccine Market Share by Type in 2019
Figure 86. Asia Pacific Tetanus Toxoid Vaccine Market Share by Application in 2019
Figure 87. Latin America Tetanus Toxoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Tetanus Toxoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Tetanus Toxoid Vaccine Sales Market Share by Country in 2019
Figure 90. Latin America Tetanus Toxoid Vaccine Revenue Market Share by Country in 2019
Figure 91. Mexico Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Tetanus Toxoid Vaccine Market Share by Type in 2019
Figure 98. Latin America Tetanus Toxoid Vaccine Market Share by Application in 2019
Figure 99. Middle East and Africa Tetanus Toxoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Tetanus Toxoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Tetanus Toxoid Vaccine Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Tetanus Toxoid Vaccine Revenue Market Share by Country in 2019
Figure 103. Turkey Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Tetanus Toxoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Tetanus Toxoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Tetanus Toxoid Vaccine Market Share by Type in 2019
Figure 110. Middle East and Africa Tetanus Toxoid Vaccine Market Share by Application in 2019
Figure 111. North America Tetanus Toxoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America Tetanus Toxoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Tetanus Toxoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe Tetanus Toxoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Tetanus Toxoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific Tetanus Toxoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Tetanus Toxoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America Tetanus Toxoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Tetanus Toxoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa Tetanus Toxoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
ジフテリア治療の世界市場（～2026年） Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria causing severe sore throat and fever leading to narrowing of the air passages and barking cough. Diphtheria may also affect the skin, eyes, or genitals and may cause myocarditis, bleeding and kidney problems. The …- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…
- ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …
- アデノウイルスワクチンの世界市場（～2026年） Market Analysis and Insights: Global Adenovirus Vaccine Market The global Adenovirus Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adenovirus Vaccine Scope and Market Size Adenovirus Vaccine market is segment…